Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Communicating Complexity: Using intuitive visuals to help us understand the journey of GLP-1s
About This Webinar
Join us on February 3, 2026 at 10 AM EST / 4 PM CET for an insightful 30-minute interview with GLP-1 agonist researcher Condie Carmack, PhD, hosted by Rishi Desai, MD, MPH.
In this session, Dr. Carmack dives into his work in GLP-1 agonists and how using intuitive visuals helps take on the challenge of communicating complex medical topics. Discover how animation blends scientific accuracy with intuitive visuals to bring health concepts to life, helping educators, researchers, and patients deepen their understanding. Register today to reserve your spot and learn from this fascinating discussion.
Who can view: Everyone
Webinar Price: Free
Featured Presenters
MD, MPH
Dr. Rishi Desai, MD, MPH, is a dedicated pediatric infectious disease physician and a leader in health education who currently serves as the Medical Innovation Team Lead at Diffusion Studios. His academic journey began with an accelerated education at UCLA, where he earned a BS in icrobiology and Molecular Genetics by age 18 before completing medical training at UCSF and an MPH in pidemiology. Throughout his career, he has held impactful roles at the Centers for Disease Control and Prevention as an Epidemic Intelligence Service Officer and previously led the medical team at Khan Academy. Dr. Desai is also an active clinician in the telemedicine space through AmWell and has contributed to medical education for over 900,000 students and clinicians worldwide. Beyond his professional achievements, he enjoys spending time with his family, learning Dutch, and engaging in public health outreach.
PhD
Condie Carmack, PhD, is a molecular biologist and molecular immunologist currently leading Clinical Operations at Delphi Diagnostics in Houston, Texas. He earned his PhD from the University of Utah and completed
postdoctoral training at Fox Chase Cancer Center and the Medical Biology Institute. Dr. Carmack has held senior scientific and leadership roles at GenPharm, Molecular Dynamics, and Agilent Technologies, and previously served as General Manager of the Cancer Genetics Laboratory at Baylor College of Medicine. During his tenure at Fox Chase, he was involved in the development of the first quantitative PCR (qPCR) methodologies. At GenPharm, he contributed to the creation of genetically engineered mouse models that underpinned the immunotherapy discoveries later recognized with the Nobel Prize in
Physiology/Medicine awarded to James P. Allison in 2018. Today, both quantitative PCR testing and immune checkpoint inhibitors represent multibillion-dollar global industries. Outside the laboratory, he is exploring 3D printing as a tool to create physical molecular models that aid in visualizing and teaching receptor–drug interactions and molecular mechanisms of
action.
postdoctoral training at Fox Chase Cancer Center and the Medical Biology Institute. Dr. Carmack has held senior scientific and leadership roles at GenPharm, Molecular Dynamics, and Agilent Technologies, and previously served as General Manager of the Cancer Genetics Laboratory at Baylor College of Medicine. During his tenure at Fox Chase, he was involved in the development of the first quantitative PCR (qPCR) methodologies. At GenPharm, he contributed to the creation of genetically engineered mouse models that underpinned the immunotherapy discoveries later recognized with the Nobel Prize in
Physiology/Medicine awarded to James P. Allison in 2018. Today, both quantitative PCR testing and immune checkpoint inhibitors represent multibillion-dollar global industries. Outside the laboratory, he is exploring 3D printing as a tool to create physical molecular models that aid in visualizing and teaching receptor–drug interactions and molecular mechanisms of
action.
Hosted By
Recommended